[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
CYBN receives MHRA approval for Phase X EMBRACE study for CYB003, driving investor confidence. Trading volume spikes as the psychedelic sector gains momentum, with CYBN leading the charge.
CYBN is a company focused on the development of psychedelic-based therapeutics for mental health disorders.
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXX
1 Week: XXXXXX +97%
1 Month: XXXXXXX -XXXX%
1-Year High: XXXXXX on 2025-05-27
1-Year Low: XXX on 2025-04-27
Social Network | X | YouTube |
---|---|---|
Engagements | XXXXXX | X |
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +70%
1 Month: XXXXX +174%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-27
Social Network | X | YouTube |
---|---|---|
Mentions | XXX | X |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $cybn in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +29%
1 Month: XXX +768%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-27
The most influential creators that mention $cybn in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@PsychedStocks | X | XXX | X | XXXXX |
@Andre_AGTC | X | XXXXX | X | XXXXX |
@PsychedVantage | X | XXXXX | X | XXX |
@Quantumup1 | X | XXXXX | X | XXX |
@AlphaGenomeAI | X | XX | X | XXX |
@psil_ai | X | XX | X | XXX |
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +11%
1 Month: XX% +25%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-05-15
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXXX | XX% | XX | X% |
YouTube | X | X% | X | X% | X | X% |
Total | XXXXX | XX% | XXXXXX | XX% | XX | X% |
Top assets mentioned In the posts about $cybn in the last XX hours
ATAI Life Sciences (ATAI) Bitcoin Incognito (XBI) Johnson & Johnson (JNJ) Rocket Lab USA, Inc. Common Stock (RKLB) ATAI Life Sciences (ATAI) Landwolf (WOLF) DMarket (DMT) Hasbro, Inc. (HAS) Taraxa (TARA) Skyworks Solutions Inc (SWKS)
Top topics mentioned In the posts about $cybn in the last XX hours
$cmps, $atai, $mnmd, $psyk, $ftrp, $ghrs, $numif, $rvvtf, stocks, mental health, momentum, rklb, numi, investment, $silo, $drug, regulatory, $cmnd, pltr, $xbi, mira, $jnj, ixhl, $rklb, market cap, $psil, alt, atai life, crv, $phrrf, stockmarket, labu, $edit, opti, $mgx, $ixhl, $medi, $alec, $nvct, $rlmd, cgc, $envb, $prme, $72m, $eltp, sndl, $phrm, $wppl, iwm, qqq, spy, $psyc, fund manager, money, compound, $wesa, watchlist, $prax, $crdf, $athe, drugs, $weedto, $nehc, Sentiment, manat, rating agency, $arkg, breakthrough, oscr, $numi, $seel, op, $havn, arct, 100m, iv, volatility, coco, $aqms, $grov, $stim, $evtl, $wolf, $bynd, $ktta, $alls, fro, spx, telo, dtc, $iwm, $dmt, $agn, 25m, $23m, $26m, $fh, $22m, $labu, $vtgn
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$CYBN CYB003 marks new enrollment milestone. Phase X depression trial participation surges. Psilocybin-based therapy gaining traction. $CMPS $MNMD $ATAI $PSYK"
@PsychedStocks on X 2025-07-25 20:25:16 UTC XXX followers, XXX engagements
"$ATAI down -XX% after hours on Phase 2b data for Schizophrenia drug ⛔ There was only a XX% chance of success anyways 🤷♂ $XBI $CYBN $MNMD $CMPS 🍄 Rotation into Cannabis stock then for DEA S3 hopefully around September 2025 🔮 $MSOS $CGC $TLRY $GTBIF $TCNNF $CURLF $VRNOF 🌿"
@c2412345 on X 2025-07-25 20:23:13 UTC XXX followers, 1464 engagements
"$CYBN CYB003 Phase X readout promising in depression Primary endpoint met with positive data Positioning strongly in psychedelic therapies $CMPS $MNMD $ATAI $PSYK"
@PsychedStocks on X 2025-07-25 19:25:08 UTC XXX followers, XXX engagements
""Phase X study EMBRACE part of PARADIGM program for CYB003 receives UK approval. Expected enrollment of XXX participants to generate critical data for MDD treatment. #clinicaltrials" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-25 19:01:17 UTC XX followers, XXX engagements